The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.

Evidence Rating Level: 2 (Good) Study Rundown: Hydroxychloroquine has been proposed as a potential treatment option for ...

As many as 50 million Americans suffer autoimmune conditions. A Stanford Medicine study identified a gap in the research—and ...

Avery Mills has been experiencing chronic health issues for quite some time and was unable to get a diagnosis. However, the 90-Day Fiance: Before the 90-Day alum can finally put a name to her ...

The Vagus Nerve’s Mysterious Role in Mental Health Untangled ...

Discover how Cori "Chocc" Broadus channels her lupus journey into empowering music and advocacy, becoming a voice for ...

Study reveals that achieving low disease activity or remission in lupus patients with high disease activity reduces organ ...

The new administration wants “a break” from infectious disease research to focus on chronic disease. That’s impossible, ...

Yes, lupus can affect your voice. Lupus can cause inflammation and tissue damage, leading to hoarseness, vocal fatigue, and ...

Lupus and menopause can interact in complex ways, with menopause sometimes worsening lupus symptoms or, in other cases, ...

In a new study, researchers evaluated the treatment effects of BI655064, an anti-CD40 monoclonal antibody, as an add-on ...

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.